• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母生产的乙型肝炎疫苗。

Hepatitis B vaccine produced in yeast.

作者信息

Bitter G A, Egan K M, Burnette W N, Samal B, Fieschko J C, Peterson D L, Downing M R, Wypych J, Langley K E

机构信息

Amgen, Thousand Oaks, California 91320.

出版信息

J Med Virol. 1988 Jun;25(2):123-40. doi: 10.1002/jmv.1890250202.

DOI:10.1002/jmv.1890250202
PMID:3292698
Abstract

A gene encoding the 226 amino acid hepatitis B surface antigen (HBsAg), subtype adw, was cloned into a generalized vector for the expression of heterologous genes in Saccharomyces cerevisiae. The 5' end of the genomic HBsAg gene was replaced with a chemically synthesized DNA segment that conserved the amino acid sequence of the protein but utilized DNA sequences that optimize translation initiation in yeast. High-cell-density fermentations of laboratory strains of Saccharomyces cerevisiae have been developed in which HBsAg production increases linearly with respect to cell mass. The HBsAg is present as a lipoprotein particle in cell lysates and has been purified to homogeneity. The evidence presented indicates that the HBsAg particles may be formed during lysis of the yeast cells. The purified HBsAg particles have a morphology similar to that of the 22 nm particles present in the serum of human chronic carriers of hepatitis B. The reactivity of the yeast-derived HBsAg particles with a series of monoclonal antibodies is essentially identical to that of human plasma HBsAg. By this analysis, therefore, the structure of the HBsAg protein is similar in yeast and in human particles. The purified yeast HBsAg particles were formulated with alum adjuvant and subsequently were shown to confer immunity in chimpanzees to challenge with two heterologous serotypes (adr, ayw) of hepatitis B virus.

摘要

编码226个氨基酸的乙型肝炎表面抗原(HBsAg)adw亚型的基因被克隆到一个用于在酿酒酵母中表达异源基因的通用载体中。基因组HBsAg基因的5'端被一个化学合成的DNA片段取代,该片段保留了蛋白质的氨基酸序列,但使用了优化酵母中翻译起始的DNA序列。已开发出酿酒酵母实验室菌株的高细胞密度发酵方法,其中HBsAg的产量随细胞量呈线性增加。HBsAg以脂蛋白颗粒的形式存在于细胞裂解物中,并已纯化至同质。所提供的证据表明,HBsAg颗粒可能在酵母细胞裂解过程中形成。纯化的HBsAg颗粒的形态与慢性乙型肝炎携带者血清中存在的22 nm颗粒相似。酵母来源的HBsAg颗粒与一系列单克隆抗体的反应性与人类血浆HBsAg基本相同。因此,通过这种分析,HBsAg蛋白在酵母颗粒和人类颗粒中的结构相似。纯化的酵母HBsAg颗粒与明矾佐剂一起配制,随后在黑猩猩中显示出对两种异源血清型(adr、ayw)乙型肝炎病毒攻击的免疫保护作用。

相似文献

1
Hepatitis B vaccine produced in yeast.酵母生产的乙型肝炎疫苗。
J Med Virol. 1988 Jun;25(2):123-40. doi: 10.1002/jmv.1890250202.
2
Production and immunological analysis of recombinant hepatitis B vaccine.
J Infect. 1986 Jul;13 Suppl A:3-9. doi: 10.1016/s0163-4453(86)92563-6.
3
Human hepatitis B vaccine from recombinant yeast.重组酵母乙型肝炎疫苗
Nature. 1984;307(5947):178-80. doi: 10.1038/307178a0.
4
Recombinant yeast hepatitis B vaccine.重组酵母乙型肝炎疫苗
Dev Biol Stand. 1986;63:57-62.
5
Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.源自酵母细胞(多形汉逊酵母)的乙肝表面抗原(HBsAg)用于确定抗原亚型(adw2、adr、ayw3)在测量疫苗接种后免疫反应方面的影响。
Vaccine. 2002 May 22;20(17-18):2191-6. doi: 10.1016/s0264-410x(02)00145-7.
6
Properties of recombinant hepatitis B vaccine.
Biochem Biophys Res Commun. 1987 Dec 31;149(3):1172-8. doi: 10.1016/0006-291x(87)90531-6.
7
Subunit, recombinant and synthetic hepatitis B vaccines.亚单位、重组及合成乙型肝炎疫苗。
Scand J Gastroenterol Suppl. 1985;117:27-38. doi: 10.3109/00365528509092225.
8
Hepatitis B surface antigen particles with all four subtypic determinants: point mutations of hepatitis B virus DNA inducing phenotypic changes or double infection with viruses of different subtypes.具有所有四种亚型决定簇的乙型肝炎表面抗原颗粒:诱导表型变化的乙型肝炎病毒DNA点突变或不同亚型病毒的双重感染。
Mol Immunol. 1990 May;27(5):443-9. doi: 10.1016/0161-5890(90)90169-z.
9
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.一种涉及乙型肝炎病毒DNA前S(2)区产物的合成肽疫苗:在黑猩猩中的保护效果。
Proc Natl Acad Sci U S A. 1986 Dec;83(23):9174-8. doi: 10.1073/pnas.83.23.9174.
10
Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients.编码主要乙肝表面抗原(HBsAg)的基因中的遗传改变:对来自单克隆抗体治疗的肝移植患者的复发性HBsAg的DNA和免疫学分析。
Hepatology. 1992 May;15(5):757-66. doi: 10.1002/hep.1840150503.

引用本文的文献

1
Insights into induction of the immune response by the hepatitis B vaccine.乙型肝炎疫苗诱导免疫应答的研究进展。
World J Gastroenterol. 2022 Aug 21;28(31):4249-4262. doi: 10.3748/wjg.v28.i31.4249.
2
Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults.
Eur J Epidemiol. 1992 Sep;8(5):650-5. doi: 10.1007/BF00145379.
3
Growth rate control in fed-batch cultures of recombinant Saccharomyces cerevisiae producing hepatitis B surface antigen (HBsAg).重组酿酒酵母分批补料培养生产乙型肝炎表面抗原(HBsAg)时的生长速率控制
Appl Microbiol Biotechnol. 1991 Apr;35(1):46-30. doi: 10.1007/BF00180634.